Relationship between immune cell markers and endometriosis explored by Mendelian Randomization method
LI Jialu1, YANG Yue1, ZHANG Xiaoli2
1. Department of Obstetrics and gynecology, Aviation General Hospital, Beijing 100123,China; 2. Department of Obstetrics and gynecology, the Third Medical Center of PLA General Hospital, Beijing 100039, China
Abstract:Objective To investigate the causal relationship between immune cell markers and endometriosis (EMs) by Mendelian randomization method. Methods Two-sample Mendelian randomization analysis (MR) was used to evaluate the causal relationship between 731 immune cell phenotypes and EMs. Inverse variance weighting method was used and sensitivity analysis was performed to verify the reliability of the results. Results Nine immunophenotypes were significantly associated with increased risk of EMs, including CD127 on T cell (OR=1.063, 95%CI:1.001-1.130, P=0.047), CD25 on CD28+ CD4+(OR=1.149, 95%CI:1.026-1.286, P=0.016), CD28 on CD39+ activated Treg (OR=1.004, 95%CI:1.015-1.081, P=0.004), CD33br HLA DR+ CD14%CD33br HLA DR+ (OR=1.035, 95%CI:1.002-1.069, P=0.036), CD45 on lymphocyte (OR=1.059, 95%CI:1.011-1.109, P=0.015), CD45 on NK cell(OR=1.042, 95%CI:1.001-1.086, P=0.046), CM CD8br AC(OR=1.060, 95%CI:1.001-1.122, P=0.046),Granulocyte AC(OR=1.060, 95%CI:1.004-1.120, P=0.035) and HLA DR+NK%NK cell (OR=1.044, 95%CI:1.000-1.090, P=0.049. Four immunophenotypes were significantly associated with reduced risk of EMs, , including CD8 on TD CD8br (OR=0.948, 95%CI:0.903-0.996, P=0.034), DN (CD4- CD8-) %leukocyte (OR=0.959, 95%CI:0.930-0.989, P=0.008),HLA DR on HLA DR+ CD8br (OR=0.933, 95%CI:0.882-0.988, P=0.018),HLA DR+T cell AC(OR=0.972, 95%CI:0.946-0.999, P=0.039), and Naive DN (CD4-CD8-) %DN (OR=0.935, 95%CI:0.878-0.995, P=0.035). The results of sensitivity analysis were consistent with the results of the main study. Conclusions There is causal relationship between immune cells and susceptibility to EMs, which provides a new direction for clinical decision making and drug development.
Kim J Y,Lee D H,Joo J K,et al.Effects of peritoneal fluid from endometriosis patients on interferon-gamma-induced protein-10 (CXCL10) and interleukin-8 (CXCL8) released by neutrophils and CD4+ T cells [J].Am J Reprod Immunol,2009,62(3):128-138.
[2]
Orrù V,Steri M,Sidore C,Marongiu M,et al.Complex genetic signatures in immune cells underlie autoimmunity and inform therapy [J].Nat Genet,2020,52(10):1036-1045.
[3]
Sidore C,Busonero F,Maschio A,et al.Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflflammatory markers [J].Nat Genet,2015,47 (11):1272-1281.
[4]
Auton A,Brooks L,Durbin R,et al.A global reference for human genetic variation [J].Nature,2015,526(7571):68-74.
[5]
Cai J,Li X,Wu S,et al.Assessing the causal association between human blood metabolites and the risk of epilepsy[J].J Trans Med,2022,20 (1):437.
[6]
Wang X,Xu W,Wang F,et al.Telomere length and development of systemic lupus erythematosus: a mendelian randomization study [J].Arthritis Rheumatol,2022,74(12):1984-1990.
[7]
Hemani G, Zheng J, Elsworth B, et al. The mrbase platform supports systematic causal inference across the human phenome[J].eLife,2018,7:e34408.
[8]
Verbanck M,Chen C,Neale B,et al.Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases[J].Nat Genet,2018,50(5):693-698.
[9]
Pan L, Chen Y, Zhou Z, et al. The correlation between immune cells and endometriosis: a bidirectional two-sample mendelian randomization study.BMC Womens Health. 2024;24(1):641. Published 2024 Dec 19.
[10]
Reis JL, Rosa NN, Martins C, et al. The Role of NK and T Cells in Endometriosis.Int J Mol Sci. 2024;25(18):10141. Published 2024 Sep 21.
[11]
Knez J, Kovacic B, Goropevsek A. The role of regulatory T-cells in the development of endometriosis.Hum Reprod. Published online May 16, 2024.
[12]
Szukiewicz D. Epigenetic regulation and T-cell responses in endometriosis-something other than autoimmunity.Front Immunol. 2022;13:943839. Published 2022 Jul 22.
[13]
Lebovic D I,Mueller M D,Taylor RN.Immunobiology of endometriosis[J].Fertil Steril,2001,75(1):1-10.
[14]
Ahn S H,Khalaj K,Young S L,et al.Immune-inflammation gene signatures in endometriosis patients[J].Fertil Steril,2016,106(6):1420-1431.
[15]
Giuliani E,Parkin K L,Lessey B A,et al.Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis[J].Am J Reprod Immunol,2014,72(3):262-269.
[16]
Kisovar A, Becker C M, Granne I, et al. The role of CD8+ T cells in endometriosis: a systematic review.Front Immunol. 2023;14:1225639. Published 2023 Jul 11.
[17]
Zhou C, Feng M, Chen Y, et al. Unraveling immunotherapeutic targets for endometriosis: a transcriptomic and single-cell analysis.Front Immunol. 2023;14:1288263. Published 2023 Nov 16.